Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00440830 · ClinicalTrials.gov registry record · Phase 4
Nicotine Patch as an Analgesic Adjuvant After Surgery
A Phase 4 study of Pain, sponsored by Columbia University.
- Completed
- Registry status
- Phase 4
- Development phase
- 68
- Enrollment target
- 1
- Study location
NCT00440830 is a Phase 4 study of Pain that has completed, run by Columbia University. The registered enrollment target is 68 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00440830, a Phase 4 study of Pain, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 68 participants
- Enrollment target
- 1
- Study location
Study Summary
Effect of nicotine patch as an adjutant for acute pain after surgery.
Conditions Studied
Interventions
- DRUG placebo
- DRUG nicotine patch
Study Locations (1)
New York
- Columbia University Irving Medical Center / New York Presbyterian - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2005-12 |
| Est. Completion | 2008-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00440830
The ClinicalTrials.gov registry entry for NCT00440830 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (78% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT00440830 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00440830 about?
NCT00440830 is a clinical study titled "Nicotine Patch as an Analgesic Adjuvant After Surgery". Effect of nicotine patch as an adjutant for acute pain after surgery.
What is the current status of trial NCT00440830?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 68 participants. The study started on 2005-12. Estimated completion is 2008-12.
What conditions does trial NCT00440830 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT00440830?
The interventions under investigation include: placebo (DRUG), nicotine patch (DRUG).
Who is sponsoring clinical trial NCT00440830?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00440830 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Magnesium on Neuromonitoring
RECRUITING · Phase 4
-
Low-Dose Ketamine Infusion During Burn Wound Care
RECRUITING · Phase 4
-
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
RECRUITING · Phase 4
-
Optimizing Pain Control in Transurethral Resection of the Prostate
RECRUITING · Phase 4
-
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
RECRUITING · Phase 4
-
Regional Blocks for Lateral Condyle Fractures
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.